Stanford tests Pfizer vaccine on children 5 and younger

Video provided by Stanford shows volunteers as young as 2 years old during phase one of this trial.

Federal, state, local officials encourage state's Black residents to get COVID-19 vaccine

A group of Black federal, state and local officials encouraged the state's Black and African American residents Wednesday to get vaccinated against the coronavirus as soon as they can.

US weighs next steps for J&J vaccine after rare cases of blood clots

A three-hour emergency meeting was held virtually from the CDC hub in Atlanta where dozens of the nation’s medical leaders investigated the cases of the six women who became ill after taking the J&J vaccine.

J&J COVID-19 vaccine pause to remain in place while officials seek more evidence on rare clots

The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.

Moderna CEO says company anticipates ‘a lot of variants’ of coronavirus in next year

Moderna CEO Stéphane Bancel said he anticipates the world will see many coronavirus variants over “the next year or so” and hopes to have a booster shot by the fall.

NFL says more than 2M COVID-19 vaccines administered at its stadiums

The NFL announced Wednesday that more than 2 million COVID-19 vaccinations have been administered at its stadiums and facilities since starting the campaign earlier this year.

CDC investigating death possibly connected to Johnson & Johnson vaccine

The death of a woman who received the single-dose Johnson & Johnson vaccine is under investigation by federal health authorities as part of a broader probe into potential "adverse side effects" from the vaccine.

SF opens COVID vaccine eligibility to all residents ages 16 and older

The expansion comes one week after the city expanded eligibility to all residents age 16 and older in several prioritized ZIP codes that have been hit hardest by the pandemic.

Moderna says its COVID-19 vaccine greater than 90% effective against virus 6 months after second shot

Moderna said its latest Phase 3 clinical trial found that its vaccine remains greater than 90% effective against COVID-19, and greater than 95% effective against severe cases of COVID-19, six months after the second dose.

Newsom: J&J vaccine pause won’t affect California reopening

State officials directed counties and other providers on Tuesday to halt use of the vaccine per federal recommendation. But Gov. Gavin Newsom said he does not expect the halt to “materially impact our ability to fulfill our expectations

Georgia site stops Johnson & Johnson vaccinations after adverse reactions

A Georgia COVID-19 vaccination site is pausing using the Johnson & Johnson vaccine after multiple people experienced adverse reactions.

Regeneron’s COVID-19 antibody drug prevents symptomatic infection by 81%, study finds

Regeneron said it now plans to request FDA clearance to use the COVID-19 antibody drug as a preventative treatment that could help provide immediate protection to unvaccinated people.